ArticleFrontiers in oncology2025
MM-3D Unet: development of a lightweight breast cancer tumor segmentation network utilizing multi-task and depthwise separable convolution.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: This paper introduces a novel lightweight MM-3DUNet (Multi-task Mobile 3D UNet) network designed for efficient and accurate segmentation of breast cancer tumors masses from MRI images, which leverages depth-wise separable convolutions, channel expansion units, and auxiliary classification tasks to enhance feature representation and computational efficiency. Methods: We propose a 3D depth-wise separable convolution, and construct channel expansional convolution (CEC) unit and inverted residual block (IRB) to reduce the parameter count and computational load, making the network more suitable for use in resource-constrained environments. In addition, an auxiliary classification task (ACT) is introduced in the proposed architecture to provide additional supervisory signals for the main task of segmentation. The network architecture features a contracting path for downsampling and an expanding path for precise localization, enhanced by skip connections that integrate multi-level semantic information. Results: The network was evaluated using a dataset of Dynamic Contrast Enhanced MRI (DCE-MRI) breast cancer images, and the results show that compared to the classical 3DU-Net, MM-3DUNet could significantly reduce model parameters by 63.16% and computational demands by 80.90%, while increasing segmentation accuracy by 1.30% in IoU (Intersection over Union). Conclusions: MM-3DUNet offers a substantial reduction in computational requirements of breast cancer mass segmentation network. This network not only enhances diagnostic precision but also supports deployment in diverse clinical settings, potentially improving early detection and treatment outcomes for breast cancer patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.